Sangtec Molecular Licenses DxS s Scorpions Technology | GenomeWeb

NEW YORK, Feb. 18 (GenomeWeb News) -  Sangtec Molecular Diagnostics has licensed the Scorpions genotyping technology from DxS in order to develop in vitro  diagnostics, the companies said today.

Financial details of the deal were not disclosed.

Scorpions is a fluorescence-based nucleic acid detection and genotyping system developed by DxS, a genetic analysis services provider. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.